Targeted therapies in oncology:
Saved in:
| Format: | Electronic eBook |
|---|---|
| Language: | English |
| Published: |
Boca Raton
CRC Press, Taylor & Francis Group
2014
|
| Edition: | Second edition |
| Subjects: | |
| Item Description: | Print version record |
| Physical Description: | 1 online resource (pages) |
| ISBN: | 9781842145463 1842145460 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044357933 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170620s2014 |||| o||u| ||||||eng d | ||
| 020 | |a 9781842145463 |9 978-1-84214-546-3 | ||
| 020 | |a 1842145460 |9 1-84214-546-0 | ||
| 035 | |a (ZDB-4-NLEBK)ocn859154865 | ||
| 035 | |a (OCoLC)859154865 | ||
| 035 | |a (DE-599)BVBBV044357933 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 616.99/406 |2 23 | |
| 245 | 1 | 0 | |a Targeted therapies in oncology |c edited by Giuseppe Giaccone and Jean-Charles Soria |
| 250 | |a Second edition | ||
| 264 | 1 | |a Boca Raton |b CRC Press, Taylor & Francis Group |c 2014 | |
| 300 | |a 1 online resource (pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Print version record | ||
| 505 | 8 | |a The role of next generation sequencing technologies / Siddhartha Devarakonda, Daniel Morgensztern and Ramaswamy Govindan -- Signal transduction inhibitors of the HER family / Christina Brzezniak [and others] -- HER-2 inhibition and clinical achievements / Berta Sousa, J. Ribeiro and Fatima Cardoso -- Inhibiting the phosphoinositide 3-kinase/akt/mammaliantarget of rapamycin pathway / Simona Wagner and Janet E. Dancey -- BRAF and MEK inhibitors / Lidia Robert and Antoni Ribas -- KIT and KIT inhibitors / Jean-Yves Blay [and others] -- Targeting the fibroblast growth factor receptor (FGFR) pathway in human cancer / Maria Vittoria Dieci and Fabrice Andre -- Anaplastic lymphoma kinase (ALK) / Aparna Rao and Benjamin Solomon -- MET inhibitors / Apoorva Chawla, Ravi Salgia and Victoria M. Villaflor -- Targeting stem cells / Marcello Maugeri-Saccà and Ruggero De Maria -- The cancer super-chaperone Hsp90 : its posttranslational regulation and drug targeting / Annerleim Walton-Diaz [and others] -- Targeting apoptosis pathways / Pamela M. Holland, David Reese, and Jeffrey Wiezorek -- Targeting angiogenesis / Sophie Postel-Vinay and Jean-Pierre Armand -- Anti-vascular agents / Gianluca Del Conte and Cristiana Sessa -- Immunotherapy : monoclonal antibodies / Patrick M. Forde and Julie R. Brahmer -- Vaccine therapy and integration with other modalities / Benedetto Farsaci [and others] -- Histone deacetylase inhibitors as targeted therapies / Alexandra Zimmer [and others] -- Compounds, targeting androgen pathways / Aurelius Omlin, Carmel Pezaro, and Johann de Bono -- Targeting DNA repair : PARP and Chk1 inhibitors / Peter Stephens and Ruth Plummer -- Inhibitors targeting mitosis / Dan L. Sackett, Edina Komlodi-Pasztor, and Tito Fojo | |
| 650 | 4 | |a Neoplasms / therapy | |
| 650 | 4 | |a Genetic Therapy | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Molecular Targeted Therapy | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / General |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Clinical Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Diseases |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Evidence-Based Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Internal Medicine |2 bisacsh | |
| 650 | 7 | |a Cancer / Treatment |2 fast | |
| 650 | 4 | |a Evidenz-basierte Medizin | |
| 650 | 4 | |a Innere Medizin | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Cancer |x Treatment | |
| 700 | 1 | |a Giaccone, Giuseppe |e Sonstige |4 oth | |
| 700 | 1 | |a Soria, Jean-Charles |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Targeted therapies in oncology |b Second edition |z 9781842145456 |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029760564 | ||
Record in the Search Index
| _version_ | 1804177603271065600 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV044357933 |
| collection | ZDB-4-NLEBK |
| contents | The role of next generation sequencing technologies / Siddhartha Devarakonda, Daniel Morgensztern and Ramaswamy Govindan -- Signal transduction inhibitors of the HER family / Christina Brzezniak [and others] -- HER-2 inhibition and clinical achievements / Berta Sousa, J. Ribeiro and Fatima Cardoso -- Inhibiting the phosphoinositide 3-kinase/akt/mammaliantarget of rapamycin pathway / Simona Wagner and Janet E. Dancey -- BRAF and MEK inhibitors / Lidia Robert and Antoni Ribas -- KIT and KIT inhibitors / Jean-Yves Blay [and others] -- Targeting the fibroblast growth factor receptor (FGFR) pathway in human cancer / Maria Vittoria Dieci and Fabrice Andre -- Anaplastic lymphoma kinase (ALK) / Aparna Rao and Benjamin Solomon -- MET inhibitors / Apoorva Chawla, Ravi Salgia and Victoria M. Villaflor -- Targeting stem cells / Marcello Maugeri-Saccà and Ruggero De Maria -- The cancer super-chaperone Hsp90 : its posttranslational regulation and drug targeting / Annerleim Walton-Diaz [and others] -- Targeting apoptosis pathways / Pamela M. Holland, David Reese, and Jeffrey Wiezorek -- Targeting angiogenesis / Sophie Postel-Vinay and Jean-Pierre Armand -- Anti-vascular agents / Gianluca Del Conte and Cristiana Sessa -- Immunotherapy : monoclonal antibodies / Patrick M. Forde and Julie R. Brahmer -- Vaccine therapy and integration with other modalities / Benedetto Farsaci [and others] -- Histone deacetylase inhibitors as targeted therapies / Alexandra Zimmer [and others] -- Compounds, targeting androgen pathways / Aurelius Omlin, Carmel Pezaro, and Johann de Bono -- Targeting DNA repair : PARP and Chk1 inhibitors / Peter Stephens and Ruth Plummer -- Inhibitors targeting mitosis / Dan L. Sackett, Edina Komlodi-Pasztor, and Tito Fojo |
| ctrlnum | (ZDB-4-NLEBK)ocn859154865 (OCoLC)859154865 (DE-599)BVBBV044357933 |
| dewey-full | 616.99/406 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/406 |
| dewey-search | 616.99/406 |
| dewey-sort | 3616.99 3406 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | Second edition |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03478nmm a2200517zc 4500</leader><controlfield tag="001">BV044357933</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170620s2014 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781842145463</subfield><subfield code="9">978-1-84214-546-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1842145460</subfield><subfield code="9">1-84214-546-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-NLEBK)ocn859154865</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)859154865</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044357933</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/406</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Targeted therapies in oncology</subfield><subfield code="c">edited by Giuseppe Giaccone and Jean-Charles Soria</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton</subfield><subfield code="b">CRC Press, Taylor & Francis Group</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Print version record</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">The role of next generation sequencing technologies / Siddhartha Devarakonda, Daniel Morgensztern and Ramaswamy Govindan -- Signal transduction inhibitors of the HER family / Christina Brzezniak [and others] -- HER-2 inhibition and clinical achievements / Berta Sousa, J. Ribeiro and Fatima Cardoso -- Inhibiting the phosphoinositide 3-kinase/akt/mammaliantarget of rapamycin pathway / Simona Wagner and Janet E. Dancey -- BRAF and MEK inhibitors / Lidia Robert and Antoni Ribas -- KIT and KIT inhibitors / Jean-Yves Blay [and others] -- Targeting the fibroblast growth factor receptor (FGFR) pathway in human cancer / Maria Vittoria Dieci and Fabrice Andre -- Anaplastic lymphoma kinase (ALK) / Aparna Rao and Benjamin Solomon -- MET inhibitors / Apoorva Chawla, Ravi Salgia and Victoria M. Villaflor -- Targeting stem cells / Marcello Maugeri-Saccà and Ruggero De Maria -- The cancer super-chaperone Hsp90 : its posttranslational regulation and drug targeting / Annerleim Walton-Diaz [and others] -- Targeting apoptosis pathways / Pamela M. Holland, David Reese, and Jeffrey Wiezorek -- Targeting angiogenesis / Sophie Postel-Vinay and Jean-Pierre Armand -- Anti-vascular agents / Gianluca Del Conte and Cristiana Sessa -- Immunotherapy : monoclonal antibodies / Patrick M. Forde and Julie R. Brahmer -- Vaccine therapy and integration with other modalities / Benedetto Farsaci [and others] -- Histone deacetylase inhibitors as targeted therapies / Alexandra Zimmer [and others] -- Compounds, targeting androgen pathways / Aurelius Omlin, Carmel Pezaro, and Johann de Bono -- Targeting DNA repair : PARP and Chk1 inhibitors / Peter Stephens and Ruth Plummer -- Inhibitors targeting mitosis / Dan L. Sackett, Edina Komlodi-Pasztor, and Tito Fojo</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic Therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molecular Targeted Therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Clinical Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Evidence-Based Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Internal Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Evidenz-basierte Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Innere Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Giaccone, Giuseppe</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Soria, Jean-Charles</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="t">Targeted therapies in oncology</subfield><subfield code="b">Second edition</subfield><subfield code="z">9781842145456</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029760564</subfield></datafield></record></collection> |
| id | DE-604.BV044357933 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:50:42Z |
| institution | BVB |
| isbn | 9781842145463 1842145460 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029760564 |
| oclc_num | 859154865 |
| open_access_boolean | |
| physical | 1 online resource (pages) |
| psigel | ZDB-4-NLEBK |
| publishDate | 2014 |
| publishDateSearch | 2014 |
| publishDateSort | 2014 |
| publisher | CRC Press, Taylor & Francis Group |
| record_format | marc |
| spelling | Targeted therapies in oncology edited by Giuseppe Giaccone and Jean-Charles Soria Second edition Boca Raton CRC Press, Taylor & Francis Group 2014 1 online resource (pages) txt rdacontent c rdamedia cr rdacarrier Print version record The role of next generation sequencing technologies / Siddhartha Devarakonda, Daniel Morgensztern and Ramaswamy Govindan -- Signal transduction inhibitors of the HER family / Christina Brzezniak [and others] -- HER-2 inhibition and clinical achievements / Berta Sousa, J. Ribeiro and Fatima Cardoso -- Inhibiting the phosphoinositide 3-kinase/akt/mammaliantarget of rapamycin pathway / Simona Wagner and Janet E. Dancey -- BRAF and MEK inhibitors / Lidia Robert and Antoni Ribas -- KIT and KIT inhibitors / Jean-Yves Blay [and others] -- Targeting the fibroblast growth factor receptor (FGFR) pathway in human cancer / Maria Vittoria Dieci and Fabrice Andre -- Anaplastic lymphoma kinase (ALK) / Aparna Rao and Benjamin Solomon -- MET inhibitors / Apoorva Chawla, Ravi Salgia and Victoria M. Villaflor -- Targeting stem cells / Marcello Maugeri-Saccà and Ruggero De Maria -- The cancer super-chaperone Hsp90 : its posttranslational regulation and drug targeting / Annerleim Walton-Diaz [and others] -- Targeting apoptosis pathways / Pamela M. Holland, David Reese, and Jeffrey Wiezorek -- Targeting angiogenesis / Sophie Postel-Vinay and Jean-Pierre Armand -- Anti-vascular agents / Gianluca Del Conte and Cristiana Sessa -- Immunotherapy : monoclonal antibodies / Patrick M. Forde and Julie R. Brahmer -- Vaccine therapy and integration with other modalities / Benedetto Farsaci [and others] -- Histone deacetylase inhibitors as targeted therapies / Alexandra Zimmer [and others] -- Compounds, targeting androgen pathways / Aurelius Omlin, Carmel Pezaro, and Johann de Bono -- Targeting DNA repair : PARP and Chk1 inhibitors / Peter Stephens and Ruth Plummer -- Inhibitors targeting mitosis / Dan L. Sackett, Edina Komlodi-Pasztor, and Tito Fojo Neoplasms / therapy Genetic Therapy Immunotherapy Molecular Targeted Therapy HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Cancer / Treatment fast Evidenz-basierte Medizin Innere Medizin Medizin Cancer Treatment Giaccone, Giuseppe Sonstige oth Soria, Jean-Charles Sonstige oth Erscheint auch als Druck-Ausgabe Targeted therapies in oncology Second edition 9781842145456 |
| spellingShingle | Targeted therapies in oncology The role of next generation sequencing technologies / Siddhartha Devarakonda, Daniel Morgensztern and Ramaswamy Govindan -- Signal transduction inhibitors of the HER family / Christina Brzezniak [and others] -- HER-2 inhibition and clinical achievements / Berta Sousa, J. Ribeiro and Fatima Cardoso -- Inhibiting the phosphoinositide 3-kinase/akt/mammaliantarget of rapamycin pathway / Simona Wagner and Janet E. Dancey -- BRAF and MEK inhibitors / Lidia Robert and Antoni Ribas -- KIT and KIT inhibitors / Jean-Yves Blay [and others] -- Targeting the fibroblast growth factor receptor (FGFR) pathway in human cancer / Maria Vittoria Dieci and Fabrice Andre -- Anaplastic lymphoma kinase (ALK) / Aparna Rao and Benjamin Solomon -- MET inhibitors / Apoorva Chawla, Ravi Salgia and Victoria M. Villaflor -- Targeting stem cells / Marcello Maugeri-Saccà and Ruggero De Maria -- The cancer super-chaperone Hsp90 : its posttranslational regulation and drug targeting / Annerleim Walton-Diaz [and others] -- Targeting apoptosis pathways / Pamela M. Holland, David Reese, and Jeffrey Wiezorek -- Targeting angiogenesis / Sophie Postel-Vinay and Jean-Pierre Armand -- Anti-vascular agents / Gianluca Del Conte and Cristiana Sessa -- Immunotherapy : monoclonal antibodies / Patrick M. Forde and Julie R. Brahmer -- Vaccine therapy and integration with other modalities / Benedetto Farsaci [and others] -- Histone deacetylase inhibitors as targeted therapies / Alexandra Zimmer [and others] -- Compounds, targeting androgen pathways / Aurelius Omlin, Carmel Pezaro, and Johann de Bono -- Targeting DNA repair : PARP and Chk1 inhibitors / Peter Stephens and Ruth Plummer -- Inhibitors targeting mitosis / Dan L. Sackett, Edina Komlodi-Pasztor, and Tito Fojo Neoplasms / therapy Genetic Therapy Immunotherapy Molecular Targeted Therapy HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Cancer / Treatment fast Evidenz-basierte Medizin Innere Medizin Medizin Cancer Treatment |
| title | Targeted therapies in oncology |
| title_auth | Targeted therapies in oncology |
| title_exact_search | Targeted therapies in oncology |
| title_full | Targeted therapies in oncology edited by Giuseppe Giaccone and Jean-Charles Soria |
| title_fullStr | Targeted therapies in oncology edited by Giuseppe Giaccone and Jean-Charles Soria |
| title_full_unstemmed | Targeted therapies in oncology edited by Giuseppe Giaccone and Jean-Charles Soria |
| title_short | Targeted therapies in oncology |
| title_sort | targeted therapies in oncology |
| topic | Neoplasms / therapy Genetic Therapy Immunotherapy Molecular Targeted Therapy HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Cancer / Treatment fast Evidenz-basierte Medizin Innere Medizin Medizin Cancer Treatment |
| topic_facet | Neoplasms / therapy Genetic Therapy Immunotherapy Molecular Targeted Therapy HEALTH & FITNESS / Diseases / General MEDICAL / Clinical Medicine MEDICAL / Diseases MEDICAL / Evidence-Based Medicine MEDICAL / Internal Medicine Cancer / Treatment Evidenz-basierte Medizin Innere Medizin Medizin Cancer Treatment |
| work_keys_str_mv | AT giacconegiuseppe targetedtherapiesinoncology AT soriajeancharles targetedtherapiesinoncology |